Use of tiotropium in patients with COPD aged 80 years and older

作者：Satoh Hiroaki^*; Kagohashi Katsunori; Ohara Gen; Sato Shinya; Miyazaki Kunihiko; Nakazawa Kensuke; Tamura Tomohiro; Kurishima Koichi; Kawaguchi Mio; Hizawa Nobuyuki

来源：Experimental and Therapeutic Medicine, 2013, 5(4): 997-1000.

DOI：10.3892/etm.2013.956

• chronic obstructive pulmonary disease
• tiotropium
• elderly
• octogenarian
• comorbid disease

The purpose of this study was to examine clinical features and treatment modality approaches in patients with chronic obstructive pulmonary disease (COPD), particularly in those aged 80 years and older. Using databases available at Mito Kyodo General Hospital (Japan), the medical records of COPD patients between April 2009 and December 2011 were retrospectively reviewed. The patient population was divided into three age groups; less than 70 years (the %26lt;70 age group), between 70-79 years (the 70-79 age group) and 80 years or older (the %26gt;= 80 age group). Demographic data, as well as the efficacy and safety of tiotropium, were compared between the three groups. Patients in the %26gt;= 80 age group comprised 35.6% of the study population with COPD (n=174). The %26gt;= 80 and 70-79 age groups demonstrated a higher proportion of comorbid disease compared with the %26lt;70 age group. A subjective improvement of dyspnea on effort as well as no additional adverse effects were observed in the %26gt;= 80 age group, similar to the other two age groups. However, higher incidence of acute exacerbation of COPD in patients aged %26gt;= 80 years old was found, particularly in those with comorbid disease. The efficacy and safety of tiotropium in COPD patients in the %26gt;= 80 age group were almost identical to patients %26lt;80 years old, however, physicians must be cautious with acute exacerbation of COPD in the extremely elderly population with comorbid disease.

• 出版日期2013-4